Kairos Pharma, Ltd.

KAPA us
$1.72
▼ 0.05 (-2.83%)
Volume: 42,250 · 2026-09-25

📈 Price Chart

Loading…
RSI (14)

🧭 Style Verdicts

🚀 Momentum 44
  • 21d momentum -5.5%
  • RSI 43
🎯 Pullback 50
  • -1.1% vs 20MA
💎 Value 58
  • -82% off 52w high

Scores (0–100) derived from live technical & fundamental metrics. Not investment advice.

📐 Technicals

RSI(14)42.5
MACD+0.022
MA trendMixed
ATR8.08%
21d mom.-5.5%
63d mom.-29.8%
vs 20MA-1.1%
RVOL(20)0.41×
52w low · 2 52w high · 10
-82.1% from 52-week high
20d support 2 · resistance 2

Computed live from daily OHLCV · as of 2026-09-25

🏦 Fundamentals

Market cap$6M
PER—
PBR1.43
PSR—
EPS$-1.71
ROE-138.5%
ROA-130.3%
Dividend yield0.00%
Debt/Equity0.00
EV/EBITDA-0.68
week1M3M6M1YYTD
-0.58% -5.49% -29.80% -58.23% -79.52% -66.31%

Valuation and profitability in USD, latest reported 2026-09-24. Period returns are price-based.

⚖️ AI Bull vs Bear

🐂 Bull
3/10
🐻 Bear
9/10

14d momentum -6.52%, daily vol 5.52%. Kairos Pharma, Ltd. sits in a bearish regime.

Derived from 14-day momentum and daily volatility on real OHLCV.

🗞 Related News

No recent news.